Mouse and cynomolgus monkey (general tox); mouse and rabbit (EFD)
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Why that species
Sequence homology to hTR template region; 100% complementary in monkey, 9/13 mouse, 11/13 rat/rabbit
“These species were selected based on sequence homology to the template region of the RNA component of human telomerase and expected relevant pharmacologic action of imetelstat across species, from human to monkey to rabbit to rodent, as well as species-specific sensitivities to known ODN class effects.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Surrogate molecule
No surrogate; clinical molecule tested in mouse, monkey and rabbit despite rodent mismatches
“Despite the mismatches, IC50 values are similar in tumour cell lines from all tested species, supporting their relevance for toxicology studies.”
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Species: DART
Mouse and rabbit (EFD)
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Species: carcinogenicity
Not conducted; mouse and rat carcinogenicity studies required as PMRs
“To address the carcinogenicity risk assessment of imetelstat, there will be separate Post Marketing Requirements (PMRs) for carcinogenicity assessments in the mouse and rat species.”
✓ VerifiedFDA multi-discipline review, p. 43Source ↗
Surrogate used in
No surrogate used; clinical molecule active across tested species
“Despite the mismatches, IC50 values are similar in tumour cell lines from all tested species, supporting their relevance for toxicology studies.”